$162.700
-1.806 (-1.11%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AZN Prediction & Forecast by Similar Chart Analysis
Alphio's AZN stock price prediction model matches the current AstraZeneca PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $162.21 (-0.30%). The 1-week path is $167.53 (+2.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy AstraZeneca PLC Stock?
AstraZeneca PLC (AZN) is a good buy right now, trading at $162.70 with a forward P/E of 16.23, indicating attractive valuation compared to its growth potential. The stock has shown a remarkable year-to-date change of +77.68% and a one-year change of +102.89%, reflecting strong performance. The recent acquisition of Zegfrovy for $600 million, with potential total commitments of $1.5 billion, demonstrates AstraZeneca's strategic growth plans in oncology, which could drive future revenue. However, the RSI is currently at 42.88, suggesting the stock is nearing oversold territory, which may present a buying opportunity. The main risk is the discontinuation of the lung cancer trial, which could affect investor sentiment and future earnings potential.
AZN stock price ended at $162.70 on Friday, after losing -1.11%
AstraZeneca PLC (AZN) last closed at $162.7, losing -1.11%. These facts feed the 1-day and 1-week AZN price prediction above.
Analyst Consensus
AstraZeneca PLC (AZN): 4 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
AstraZeneca PLC (AZN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches AZN, ranked by similarity.
Seasonality analysis for AZN
Historically the probability of a positive August return for AZN is 100.00%. May offers the highest probability of a positive month at 100.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AZN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $71.20 | $84.78 | $87.15 | -47.89% |
| Sep 2026 | $81.86 | $85.07 | $86.59 | -47.71% |
| Oct 2026 | $75.08 | $92.78 | $100.48 | -42.98% |
| Nov 2026 | $58.89 | $67.88 | $86.43 | -58.28% |
| Dec 2026 | $65.60 | $76.45 | $82.29 | -53.01% |
In 2026, AstraZeneca PLC (AZN) is projected to range from $58.89 to $100.48.
AstraZeneca PLC 2026 monthly forecast
In Aug 2026, AstraZeneca PLC is projected to average $84.78, with a low of $71.20 and high of $87.15.
In Sep 2026, AstraZeneca PLC is projected to average $85.07, with a low of $81.86 and high of $86.59.
In Oct 2026, AstraZeneca PLC is projected to average $92.78, with a low of $75.08 and high of $100.48.
In Nov 2026, AstraZeneca PLC is projected to average $67.88, with a low of $58.89 and high of $86.43.
In Dec 2026, AstraZeneca PLC is projected to average $76.45, with a low of $65.60 and high of $82.29.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.